Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2016 | Clinical significance of circulating plasma DNA in gastric cancer. | Fang, WL; Lan, YT; Huang, KH; Liu, CA; Hung, YP; Lin, CH; Jhang, FY; Chang, SC; Chen, MH; Chao, Y; Lin, WC; Lo, SS; Fen-Yau Li, A; Wu, CW; Chiou, SH; Shyr, YM | International journal of cancer 138(12), 2974-83 | | | |
1998 | Cloning and Characterization of Insulin-Like Growth Factor I cDNA from Black Seabream (Acathopagrus schlegeli) | Chen, MH; Lin, GH; Gong, HY; Lee, CY; Chang, CY; Chen, TT; Wu, JL | Zool Stud 37, 213-221 | | | |
2015 | DDX3 as A Strongest Prognosis Marker and Its Downregulation Promotes Metastasis in Colorectal Cancer | Su, CY; Lin, TC; Lin, YF; Chen, MH; Lee, CH; Wang, HY; Lee, YC; Liu, YP; Chen, CL; Hsiao, M | Oncotarget Accepted | | | |
2010 | Endozoicomonas montiporae sp. nov., isolated from the encrusting pore coral Montipora aequituberculata | Yang, C. -S.; Chen, MH; Arun, AB; Chen, C. A. ; Wang, JT; Chen, WM | INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY 60(Pt 5), 1158-1162 | | | |
2011 | Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response. | Chu, PM; Chiou, SH; Su, TL; Lee, YJ; Chen, LH; Chen, YW; Yen, SH; Chen, MT; Chen, MH; Shih, YH; Tu, PH; Ma, HI | Radiation Oncology 6, 7 | | | |
2013 | Expression of GOLM1 correlates with prognosis of human hepatocellular carcinoma | Chen, MH; Chang, PM; Hsiao, M; Jan, YH; Yeh, YC; Lei, HJ; Huang, CY; Chau, GY | Ann Surg Oncol In Revision | | | |
2013 | Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors | Chen, MH; Yeh, YC; Shyr, YM; Jan, YH; Chao, Y; Li, CP; Wang, SE; Tzeng, CH; Chang, PM; Liu, CY; Chen, MH; Hsiao, M; Huang, CY | J Gastroenterol Jan;48(1):101-108 | | | |
2009 | Gcm protein degradation suppresses proliferation of glial progenitors | Ho, MSC; Chen, HW ; Chen, MH; Jacques, C; Giangrande, A; Chien, CT | Proceedings of the National Academy of Sciences of the United States of America 106, 6778-6783 | | | |
2021 | Genome sequencing unveils a regulatory landscape of platelet reactivity | Keramati, AR; Chen, MH; Rodriguez, BAT; Yanek, LR; Bhan, A; Gaynor, BJ; Ryan, K; Brody, JA; Zhong, X; Wei, Q; Kammers, K; Kanchan, K; Iyer, K; Kowalski, MH; Pitsillides, AN; Cupples, LA; Li, B; Schlaeger, TM; Shuldiner, AR; O'Connell, JR; Ruczinski, I; Mitchell, BD; Faraday, N; Taub, MA; Becker, LC; Lewis, JP; Mathias, RA; Johnson, AD; Chang, YC ; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium | Nature communications 12(1), 3626 | | | |
2017 | Glucose transporter 4 promotes head and neck cancer metastasis through TRIM24-DDX58 axis | Chang, YC; Chi, LH; Chang, MW; Su, CY; Lin, YF; Chen, CL; Chen, MH; Chang, PM; Wu, AT; Hsiao, M | Journal of Hematology & Oncology 10(1), 11 | | | |
2001 | Hepatocyte nuclear factors-1alpha, -1beta, and -3beta expressed in the gonad of tilapia (Oreochromis mossambicus) | Huang, WT; Gong, HY; Lin, CJ; Weng, CF; Chen, MH; Wu, JL | Biochemical and Biophysical Research Communications 288, 833-840 | | | |
2017 | Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients | Yeh, CN; Chang, YC; Su, Y; Hsu, DS; Cheng, CT; Wu, RC; Chung, YH; Chiang, KC; Yeh, TS; Lu, ML; Liu, CY; Chang, PM; Chen, MH; Huang, CY; Hsiao, M ; Chen, MH | Oncotarget 8(69), 113444-113459 | | | |
2018 | miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death. | Liu, SM; Lin, CH; Lu, J; Lin, IY; Tsai, MS; Chen, MH; Ma, N | Journal of investigative dermatology 138(4), 911-921 | | | |
2016 | Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers. | Fang, WL; Huang, KH; Lan, YT; Lin, CH; Chang, SC; Chen, MH; Chao, Y; Lin, WC; Lo, SS; Li, AF; Wu, CW; Chiou, SH; Shyr, YM | Oncotarget 7(5), 6201-20 | | | |
2020 | Omics-based Platforms: Current Status and Potential Use for Cholangiocarcinoma | Chang, YC; Chen, MH; Yeh, CN; Hsiao, M | Biomolecules 10(10), 1377 | | | |
2019 | Over-expression of TNNI3K is associated with early-stage carcinogenesis of cholangiocarcinom | Yeh, CN; Chen, MH; Chang, YC; Wu, RC; Tsao, LC; Wang, SY; Cheng, CT; Chiang, KC; Chen, TW; Hsiao, M ; Weng, WH | Molecular Carcinogenesis 58(2), 270-278 | | | |
2020 | PRKDC: A New Biomarker and drug target for Checkpoint Blockade Immunotherapy | Tan, KT; Yeh, CN; Chang, YC; Cheng, JH; Fang, WL; Yeh, YC; Hsu, DS; Wu, CE; Liu, CY; Chang, MS; Lu, ML; Chen, SJ; Yee, C; Hsiao, M ; Chen, MH | Journal for ImmunoTherapy of Cancer 8(1), e000485 | | | |
2021 | Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma | Yang, YC; Chien, MH; Lai, TC; Tung, MC; Jan, YH; Chang, WM; Jung, SM; Chen, MH; Yeh, CN; Hsiao, M | JOURNAL OF BIOMEDICAL SCIENCE 28, 29 | | | |
2022 | Regorafenib inhibits epithelial-mesenchymal transition and suppresses cholangiocarcinoma metastasis via YAP1-AREG axis | Chang, YC; Li, CH; Chan, MH; Yeh, CN; Chen, MH; Hsiao, M | CELL DEATH & DISEASE 13, 391 | | | |
2021 | Ruxolitinib Combined with Gemcitabine against Cholangiocarcinoma Growth via the JAK2/STAT1/3/ALDH1A3 Pathway | Chung, SY; Hung, YP; Pan, YR; Chang, YC; Wu, CE; Hsu, DS; Chang, PM; Lu, ML; Huang, CY; Su, Y; Hsiao, M ; Yeh, CN; Chen, MH | BIOMEDICINES 9(8), 885 | | | |